$0.68
-0.08 (-10.24%)
Open$0.76
Previous Close$0.76
Day High$0.77
Day Low$0.68
52W High$6.88
52W Low$0.68
Volume—
Avg Volume2.15M
Market Cap136.65M
P/E Ratio—
EPS$-0.31
SectorBiotechnology
Analyst Ratings
Strong Buy
21 analysts
Price Target
+7,754.2% upside
Current
$0.68
$0.68
Target
$53.77
$53.77
$36.32
$53.77 avg
$66.75
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.15M | 182.11M | 191.80M |
| Net Income | -66,446,946 | -42,646,254 | -48,286,720 |
| Profit Margin | -5,808.8% | -23.4% | -25.2% |
| EBITDA | -75,469,235 | -49,107,977 | -55,425,546 |
| Free Cash Flow | — | -37,978,554 | -43,960,363 |
| Rev Growth | — | -8.0% | +10.9% |
| Debt/Equity | — | 0.29 | 0.29 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $291.31 | +1.07% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $460.42 | +0.03% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $166.89 | -0.41% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $547.09 | +0.85% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $904.35 | +0.16% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $155.94 | -0.46% | 7.7 | 20.98B |